Trade Liquidia Technologies, Inc. - LQDA CFD
Add to favourite- Summary
- Historical Data
Spread | 0.06 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 12.53 |
Open | 12.25 |
1-Year Change | 80.95% |
Day's Range | 11.83 - 12.28 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Apr 24, 2024 | 12.53 | -0.40 | -3.09% | 12.93 | 13.04 | 12.40 |
Apr 23, 2024 | 12.92 | -0.27 | -2.05% | 13.19 | 13.62 | 12.86 |
Apr 22, 2024 | 13.17 | -0.17 | -1.27% | 13.34 | 13.62 | 13.06 |
Apr 19, 2024 | 13.12 | -0.45 | -3.32% | 13.57 | 13.91 | 12.50 |
Apr 18, 2024 | 13.78 | 0.22 | 1.62% | 13.56 | 14.21 | 13.50 |
Apr 17, 2024 | 13.82 | 0.68 | 5.18% | 13.14 | 13.87 | 13.14 |
Apr 16, 2024 | 13.56 | 0.14 | 1.04% | 13.42 | 13.81 | 13.42 |
Apr 15, 2024 | 13.52 | -0.44 | -3.15% | 13.96 | 14.36 | 13.52 |
Apr 12, 2024 | 13.94 | -1.15 | -7.62% | 15.09 | 15.10 | 13.58 |
Apr 11, 2024 | 15.32 | 0.54 | 3.65% | 14.78 | 15.71 | 14.68 |
Apr 10, 2024 | 14.78 | 0.23 | 1.58% | 14.55 | 15.12 | 14.47 |
Apr 9, 2024 | 14.94 | -0.15 | -0.99% | 15.09 | 15.10 | 14.57 |
Apr 8, 2024 | 15.12 | -0.37 | -2.39% | 15.49 | 15.72 | 15.08 |
Apr 5, 2024 | 15.65 | 0.61 | 4.06% | 15.04 | 15.80 | 14.98 |
Apr 4, 2024 | 15.27 | -0.08 | -0.52% | 15.35 | 15.56 | 15.15 |
Apr 3, 2024 | 15.33 | 0.24 | 1.59% | 15.09 | 15.78 | 15.09 |
Apr 2, 2024 | 15.27 | 0.40 | 2.69% | 14.87 | 15.57 | 14.83 |
Apr 1, 2024 | 14.87 | -0.57 | -3.69% | 15.44 | 15.44 | 14.60 |
Mar 28, 2024 | 14.73 | -0.20 | -1.34% | 14.93 | 15.07 | 14.25 |
Mar 27, 2024 | 15.05 | -0.51 | -3.28% | 15.56 | 15.70 | 13.96 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Liquidia Technologies, Inc. Company profile
About Liquidia Corp
Liquidia Corporation is a biopharmaceutical company that is focused on the development, manufacturing and commercialization of products, which address unmet patient needs with a focus directed towards the treatment of pulmonary hypertension (PH). The Company operates, through its wholly owned subsidiaries, Liquidia Technologies and Liquidia PAH. Liquidia Technologies has developed YUTREPIA (treprostinil) inhalation powder for the treatment of pulmonary arterial hypertension (PAH). Liquidia PAH provides the commercialization for rare disease pharmaceutical products, such as generic treprostinil injection. Its United Therapeutics developed treprostinil under the brand name Remodulin. The Company’s PRINT engineering technology allows to engineer and manufacture uniform drug particles with control over the size, three-dimensional geometric shape and chemical composition of the particles. The Company operates from over 45,000 square foot facility in Morrisville, North Carolina.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Liquidia Corp revenues increased from $740K to $12.9M. Net loss decreased 42% to $34.6M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Research and development - Balanc decrease of 40% to $18.6M (expense), Depr of Fin Lease R/O Use Assets in SGA decrease of 80% to $267K (expense).
Industry: | Pharmaceuticals (NEC) |
419 Davis Drive, Suite 100
Suite
MORRISVILLE
NORTH CAROLINA 27560
US
News
We’re partnering with Newsquawk
Filter out the noise and focus on the news that matters.
08:32, 23 April 2024US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft
The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.
15:56, 22 April 2024Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024How escalating geopolitical tensions are impacting oil markets
The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.
13:34, 4 April 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com